Cynthia Smith Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

AGIO Quotes by TradingView

Cynthia Smith is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,414 shares of AGIO, which is worth approximately $541,871. The most recent transaction as insider was on Aug 11, 2025, when has been sold 2,302 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4K
0% 3M change
55.33% 12M change
Total Value Held $541,871

Cynthia Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2025
BUY
Exercise of conversion of derivative security
-
2,302 Added 15.64%
12,414 Common Stock
Jun 20 2025
BUY
Exercise of conversion of derivative security
-
2,120 Added 17.33%
10,112 Common Stock
Aug 11 2024
BUY
Exercise of conversion of derivative security
-
2,302 Added 22.36%
7,992 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
-
3,388 Added 37.32%
5,690 Common Stock
Aug 11 2023
BUY
Exercise of conversion of derivative security
-
2,302 Added 50.0%
2,302 Common Stock

Also insider at

SPRO
Spero Therapeutics, Inc. Healthcare
TARA
Protara Therapeutics, Inc. Healthcare
AKBA
Akebia Therapeutics, Inc. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
Director
CARA
Cara Therapeutics, Inc. Healthcare
CS

Cynthia Smith

Director
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGIO